COVID-19 Patients with Acute Coronary Syndrome: Why It Is More Than A Challenging Case?
Mohamed EL Ghali Benouna1,3*, Othmane Benmallem1,3, Amine Ech-chenbouli1,3, Salim Arous1,3, Rachida Habbal1,3, Ouissal Aissaoui2,3*, Afak Nsiri2,3, Rachid Elharrar2,3, Chafik EL Kettani2,3, Lahoucine Barrou2,3
Journal Title:Annals of Case Reports & Reviews
COVID-19 is a disease caused by the SARS-COV-2 virus and was recently declared as a pandemic by WHO on March 11, 2020.
There are more than 3 million of COVID-19 patients with more than 200000 deaths.
As we observed in the previous viral epidemics, the excessive inflammatory process, hyper coagulation and hypoxia leads to an atherosclerotic plaques destabilization, which can explain the growing number of acute coronary syndrome (ACS) in this context.
We present in this essay two cases presenting respectively STEMI and NSTEMI, describing the management of their acute myocardial infarction with all the challenges that can present a COVID-19 patient during the procedure.
Keywords: COVID-19, STEMI, NSTEMI, Acute coronary syndrome, thrombotic burden.